复星医药

(600196)

0.00 0.00 (0.00%)
所属行业: 医药生物 所属概念: 分拆概念 并购重组 增发概念 交叉持股 氢能概念 甲型流感 医改概念 股权投资概念 上证红利 参股金融
∧ 返回顶部
主营业务

  生物化学产品、试剂、生物四技服务、生产销售自身开发的产品、仪器仪表、电子产品、计算机、化工原料(除危险品)、咨询服务;经营本企业自产产品及相关技术的出口业务,经营本企业生产、科研所需的原辅材料、机械设备、仪器仪表、零配件及相关技术的进口业务(企业经营涉及行政许可的凭许可证件经营)。

产品结构图

主营收入利润

[{"sr":"56.55","name":"\u897f\u836f\u7c7b\u836f\u54c1"},{"sr":"21.95","name":"\u5546\u4e1a\u96f6\u552e\u53ca\u6279\u53d1"},{"sr":"16.67","name":"\u533b\u7597\u5668\u68b0\u670d\u52a1"},{"sr":"4.83","name":"\u5176\u4ed6"}]
[{"lr":"70.88","name":"\u897f\u836f\u7c7b\u836f\u54c1"},{"lr":"6.88","name":"\u5546\u4e1a\u96f6\u552e\u53ca\u6279\u53d1"},{"lr":"17.60","name":"\u533b\u7597\u5668\u68b0\u670d\u52a1"},{"lr":"4.65","name":"\u5176\u4ed6"}]
  • 西药类药品
  • 商业零售及批发
  • 医疗器械服务
  • 其他收入

净利润每股收益

[[{"srbfb":"56.55","lrbfb":"70.88","date":"11-12-31"},{"srbfb":"17.60","lrbfb":"20.74","date":"11-06-30"},{"srbfb":"19.46","lrbfb":"23.50","date":"10-12-31"},{"srbfb":"8.19","lrbfb":"9.72","date":"10-06-30"},{"srbfb":"11.20","lrbfb":"13.42","date":"09-12-31"}],[{"srbfb":"21.95","lrbfb":"6.88","date":"11-12-31"},{"srbfb":"7.64","lrbfb":"2.16","date":"11-06-30"},{"srbfb":"8.10","lrbfb":"1.97","date":"10-12-31"},{"srbfb":"3.34","lrbfb":"0.82","date":"10-06-30"},{"srbfb":"5.25","lrbfb":"1.40","date":"09-12-31"}],[{"srbfb":"16.67","lrbfb":"17.60","date":"11-12-31"}],[{"srbfb":4.82,"lrbfb":4.65,"date":"11-12-31"},{"srbfb":7.12,"lrbfb":7.43,"date":"11-06-30"},{"srbfb":4.57,"lrbfb":5.13,"date":"10-12-31"},{"srbfb":1.58,"lrbfb":1.52,"date":"10-06-30"},{"srbfb":2.43,"lrbfb":2.33,"date":"09-12-31"}]]
科目 主营收入 收入比例 主营成本 成本比例 营业利润 利润比例 毛利率 历史
西药类药品 3,621,761,088.96 56.55% 1,891,076,781.57 47.72% 1,730,684,307.39 70.88% 47.79%
商业零售及批发 1,406,157,698.58 21.95% 1,238,061,556.06 31.24% 168,096,142.52 6.88% 11.95%
医疗器械服务 1,067,902,138.56 16.67% 638,246,094.56 16.11% 429,656,044.00 17.60% 40.23%  
其他收入 309,036,775.92 4.83% 195,607,403.65 4.94% 113,429,372.27 4.65% 36.70%  
中药品 216,535,022.50 3.38% 107,983,673.38 2.72% 108,551,349.12 4.45% 50.13%
其他 92,501,753.42 1.44% 87,623,730.27 2.21% 4,878,023.15 0.20% 5.27%
经营分析——按行业分
科目 主营收入 收入比例 主营成本 成本比例 营业利润 利润比例 毛利率 历史
数值 图示
医药工业 3,838,296,111.46 59.93%
1,999,060,454.95 50.44% 1,839,235,656.51 75.32% 47.92%
医药商业 1,406,157,698.58 21.95%
1,238,061,556.06 31.24% 168,096,142.52 6.88% 11.95%
医疗器械 1,056,643,977.49 16.50%
629,914,035.15 15.89% 426,729,942.34 17.48% 40.39%  
其他 92,501,753.42 1.44%
87,623,730.27 2.21% 4,878,023.15 0.20% 5.27%
医疗服务 11,258,161.07 0.18%
8,332,059.41 0.21% 2,926,101.66 0.12% 25.99%  
经营分析——按地区分
科目 主营收入 收入比例 主营成本 成本比例 营业利润 利润比例 毛利率 历史
数值 图示
上海 1,662,100,000.00 25.95%
0.00 -- 1,662,100,000.00 25.95% 100.00%  
江苏 915,510,000.00 14.29%
0.00 -- 915,510,000.00 14.29% 100.00%  
重庆 889,790,000.00 13.89%
0.00 -- 889,790,000.00 13.89% 100.00%  
国外 755,280,000.00 11.79%
0.00 -- 755,280,000.00 11.79% 100.00%
北京 622,030,000.00 9.71%
0.00 -- 622,030,000.00 9.71% 100.00%  
辽宁 436,220,000.00 6.81%
0.00 -- 436,220,000.00 6.81% 100.00%  
湖北 380,380,000.00 5.94%
0.00 -- 380,380,000.00 5.94% 100.00%  
四川 214,480,000.00 3.35%
0.00 -- 214,480,000.00 3.35% 100.00%  
广西 208,690,000.00 3.26%
0.00 -- 208,690,000.00 3.26% 100.00%  
河北 134,500,000.00 2.10%
0.00 -- 134,500,000.00 2.10% 100.00%  
浙江 117,910,000.00 1.84%
0.00 -- 117,910,000.00 1.84% 100.00%  
广东 56,710,000.00 0.89%
0.00 -- 56,710,000.00 0.89% 100.00%  
安徽 11,260,000.00 0.18%
0.00 -- 11,260,000.00 0.18% 100.00%